loadpatents
Patent applications and USPTO patent grants for Topouzis; Stavros.The latest application filed is for "methods for treating diabetes".
Patent | Date |
---|---|
Methods For Treating Diabetes App 20180134779 - Strassmann; Gideon ;   et al. | 2018-05-17 |
Methods For Treating Diabetes App 20160122424 - STRASSMANN; Gideon ;   et al. | 2016-05-05 |
Methods for treating diabetes Grant 9,150,643 - Strassmann , et al. October 6, 2 | 2015-10-06 |
Methods of treating fibroproliferative disorders of the kidney or reducing kidney fibrosis Grant 8,834,879 - Hart , et al. September 16, 2 | 2014-09-16 |
Method Of Treating Fibroproliferative Disorders App 20130209467 - HART; Charles E. ;   et al. | 2013-08-15 |
Method of treating fibroproliferative disorders of the heart and lung Grant 8,431,129 - Hart , et al. April 30, 2 | 2013-04-30 |
Methods Of Treating Il-tif Associated Inflammatory Or Immune Diseases Using Antibodies Against Soluble Zcytor 11 Cytokine Receptors App 20130028894 - KINDSVOGEL; Wayne R. ;   et al. | 2013-01-31 |
Method Of Treating Fibroproliferative Disorders App 20130022599 - HART; Charles E. ;   et al. | 2013-01-24 |
Method of treating fibrproliferative disorders Grant 8,298,534 - Hart , et al. October 30, 2 | 2012-10-30 |
Methods of treating IL-TIF associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors Grant 8,287,866 - Kindsvogel , et al. October 16, 2 | 2012-10-16 |
Soluble Zcytor 11 Cytokine Receptors App 20110081344 - Kindsvogel; Wayne R. ;   et al. | 2011-04-07 |
Method Of Treating Fibrproliferative Disorders App 20100291087 - Hart; Charles E. ;   et al. | 2010-11-18 |
Method of treating fibroproliferative disorders Grant 7,722,870 - Hart , et al. May 25, 2 | 2010-05-25 |
Soluble Zcytor 11 Cytokine Receptors App 20100047168 - Kindsvogel; Wayne R. ;   et al. | 2010-02-25 |
Methods for treating diabetes App 20090035297 - Strassmann; Gideon ;   et al. | 2009-02-05 |
Prok2 Antagonists And Methods Of Use App 20080219985 - Thompson; Penny J. ;   et al. | 2008-09-11 |
Method Of Treating Fibroproliferative Disorders App 20070048317 - HART; CHARLES E. ;   et al. | 2007-03-01 |
Method Of Reducing Proliferation Of Cells In A Mammal App 20070048316 - HART; CHARLES E. ;   et al. | 2007-03-01 |
Method of treating fibroproliferative disorders Grant 7,172,757 - Hart , et al. February 6, 2 | 2007-02-06 |
Methods for treating diabetes App 20060121035 - Strassmann; Gideon ;   et al. | 2006-06-08 |
Soluble Zcytor11 cytokine receptors Grant 7,045,498 - Kindsvogel , et al. May 16, 2 | 2006-05-16 |
Soluble zcytor 11 cytokine receptors App 20060068471 - Kindsvogel; Wayne R. ;   et al. | 2006-03-30 |
Compositions and methods for improving kidney function App 20050049217 - Hart, Charles E. ;   et al. | 2005-03-03 |
Compositions and methods for improving kidney function Grant 6,827,938 - Hart , et al. December 7, 2 | 2004-12-07 |
Method of treating fibroproliferative disorders App 20040043027 - Hart, Charles E. ;   et al. | 2004-03-04 |
Method of treating fibroproliferative disorders Grant 6,630,142 - Hart , et al. October 7, 2 | 2003-10-07 |
Soluble Zcytor11 cytokine receptors App 20030157096 - Kindsvogel, Wayne R. ;   et al. | 2003-08-21 |
Compositions and methods for improving kidney function App 20020183273 - Hart, Charles E. ;   et al. | 2002-12-05 |
Method of treating fibroproliferative disorders App 20020064832 - Hart, Charles E. ;   et al. | 2002-05-30 |
Methods of treating diabetes Grant 6,368,597 - Strassmann , et al. April 9, 2 | 2002-04-09 |
Methods for treating diabetes App 20020031517 - Strassmann, Gideon ;   et al. | 2002-03-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.